Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-VEGFC Polyclonal Antibody

Catalog #:   PHE70401 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P49767
Overview

Catalog No.

PHE70401

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human VEGFC (Glu47-Trp413).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Vascular endothelial growth factor C,VEGFC,Flt4-L,VEGF-C,Vascular endothelial growth factor-related protein,VRP,Flt4 ligand

Purification

Purified by antigen affinity column.

Accession

P49767

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with VEGFC antibody (PHE70401) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 44 kDa
    Observed MW: 44 kDa
  • Western Blot
    Various lysates were subjected to SDS PAGE followed by western blot with VEGFC antibody (PHE70401) at 1 μg/ml.

    Lane 1: 293T

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 47 kDa
    Observed MW: 47 kDa
  • Immunohistochemical
    Immunohistochemical analysis of mouse brain stained for VEGFC with PHE70401.
References

Advances in Molecular Imaging of VEGFRs: Innovations in Imaging and Therapeutics., PMID:40508182

VEGF-C and Lymphatic Vessel Density in Tumor Tissue of Gastric Cancer: Correlations with Pathoclinical Features and Prognosis., PMID:40361332

A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer., PMID:39891883

Decoding lymphangiogenesis in oral squamous cell carcinoma: Emphasis on clinical and histopathological determinants of regional metastasis., PMID:39541328

Immunotherapeutic Innovations in Clear Cell Renal Cell Carcinoma: Current Strategies and Future Directions., PMID:39238630

Efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer according to programmed cell death ligand 1., PMID:39171162

Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond., PMID:38927656

The RANKL inhibitor denosumab in combination with dual checkpoint inhibition is associated with increased CXCL-13 serum concentrations., PMID:38479119

Analysis of Changes in Plasma Cytokine Levels in Response to IL12 Therapy in Three Clinical Trials., PMID:38108458

Treatment for Gorham-Stout syndrome with a combination of teriparatide and denosumab., PMID:38062162

Correction: Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human antihuman VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C., PMID:37675777

Therapeutic blocking of VEGF binding to neuropilin-2 diminishes PD-L1 expression to activate antitumor immunity in prostate cancer., PMID:37134151

Promotion of Lymphangiogenesis by Targeted Delivery of VEGF-C Improves Diabetic Wound Healing., PMID:36766814

A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration., PMID:36754174

Antibody-Mediated Delivery of VEGF-C Promotes Long-Lasting Lymphatic Expansion That Reduces Recurrent Inflammation., PMID:36611965

Atorvastatin attenuates NS1 (Non-structural protein-1) of dengue type-2 serotype-induced expressions of matrix metalloproteinases in HL-60 cells, differentiated to neutrophils: Implications for the immunopathogenesis of dengue viral disease., PMID:36108401

Hypoxia-inducible factor pathway genes predict survival in metastatic clear cell renal cell carcinoma., PMID:35973929

Combination of sunitinib and 177Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer., PMID:35878454

Regulation and impact of cardiac lymphangiogenesis in pressure-overload-induced heart failure., PMID:35689481

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients., PMID:35687576

Periostin in lymph node pre-metastatic niches governs lymphatic endothelial cell functions and metastatic colonization., PMID:35567669

Implementing subtype-specific pre-clinical models of breast cancer to study pre-treatment aspirin effects., PMID:35434898

Drainage of senescent astrocytes from brain via meningeal lymphatic routes., PMID:35427759

HMGB1 Promotes Lymphangiogenesis through the Activation of RAGE on M2 Macrophages in Laryngeal Squamous Cell Carcinoma., PMID:35280439

Cabozantinib with or without Panitumumab for RAS wild-type metastatic colorectal cancer: impact of MET amplification on clinical outcomes and circulating biomarkers., PMID:35171350

Clinical Significance of Major Angiogenesis-Related Effectors in Patients with Metastatic Breast Cancer Treated with Trastuzumab-Based Regimens., PMID:34793664

Epstein-Barr Virus Induces Lymphangiogenesis and Lympth Node Metastasis via Upregulation of VEGF-C in Nasopharyngeal Carcinoma., PMID:34654722

VEGF-C/VEGFR-3 signalling in macrophages ameliorates acute lung injury., PMID:34446463

Immunohistochemical expression and prognostic significance of VEGF-C in well-differentiated thyroid cancer., PMID:34084231

Anti-Vascular Endothelial Growth Factor C Antibodies Efficiently Inhibit the Growth of Experimental Clear Cell Renal Cell Carcinomas., PMID:34067671

Expression levels of VEGF-C and VEGFR-3 in renal cell carcinoma and their association with lymph node metastasis., PMID:33850526

PCR Array Technology in Biopsy Samples Identifies Up-Regulated mTOR Pathway Genes as Potential Rejection Biomarkers After Kidney Transplantation., PMID:33681239

circEHBP1 promotes lymphangiogenesis and lymphatic metastasis of bladder cancer via miR-130a-3p/TGFβR1/VEGF-D signaling., PMID:33545359

IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors., PMID:33445787

Identifying Genetic Risk Factors for Diabetic Macular Edema and the Response to Treatment., PMID:33274237

Arterial Delivery of VEGF-C Stabilizes Atherosclerotic Lesions., PMID:33210556

Detecting cancer metastasis and accompanying protein biomarkers at single cell levels using a 3D-printed microfluidic immunoarray., PMID:33096435

Lymphatic Proliferation Ameliorates Pulmonary Fibrosis after Lung Injury., PMID:33039355

Myeloid-derived suppressor cells improve corneal graft survival through suppressing angiogenesis and lymphangiogenesis., PMID:32892499

Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract Cancer., PMID:32878766

Correlations of recurrence of gastric cancer in patients after radical surgery with serum gastrointestinal hormones, vascular endothelial growth factors and serum anti-helicobacter pylori IgG antibody., PMID:32862593

New insights into the role of co-receptor neuropilins in tumour angiogenesis and lymphangiogenesis and targeted therapy strategies., PMID:32838575

Distinct fibroblast subsets regulate lacteal integrity through YAP/TAZ-induced VEGF-C in intestinal villi., PMID:32796823

Phase Ib study of FOLFOXIRI plus ramucirumab as first-line treatment for patients with metastatic colorectal cancer., PMID:32710148

The immune-checkpoint HLA-G/ILT4 is involved in the regulation of VEGF expression in clear cell renal cell carcinoma., PMID:32620162

Lymphatic and Immune Cell Cross-Talk Regulates Cardiac Recovery After Experimental Myocardial Infarction., PMID:32404007

HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells., PMID:32375243

Analyzing the factors that influence occult metastasis in oral tongue cancer., PMID:32364349

CCL25 promotes the migration and invasion of non-small cell lung cancer cells by regulating VEGF and MMPs in a CCR9-dependent manner., PMID:32346420

Antibody-Mediated Delivery of VEGFC Ameliorates Experimental Chronic Colitis., PMID:32259068

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-VEGFC Polyclonal Antibody [PHE70401]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only